Impact of bronchodilator therapy on exercise tolerance in COPD

References

• PauwelsRARabeKFBurden and clinical features of chronic obstructive pulmonary disease (COPD)Lancet200436461362015313363
   PubMed Web of Science ®Google Scholar
• DohertyDEBriggsDDJrChronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosisClin Cornerstone2004Suppl 2S5S1615500179
   PubMedGoogle Scholar
• MackayJAmosAWomen and tobaccoRespirology2003812313012753525
   PubMed Web of Science ®Google Scholar
• ZhangHCaiBThe impact of tobacco on lung health in ChinaRespirology20038172112856737
   PubMed Web of Science ®Google Scholar
• OgaTNishimuraKTsukinoMSatoSHajiroTAnalysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health statusAm J Respir Crit Care Med200316754454912446268
   PubMed Web of Science ®Google Scholar
• MartinezFJFosterGCurtisJLCrinerGWeinmannGFishmanAPredictors of mortality in patients with emphysema and severe airflow obstructionAm J Respir Crit Care Med20061731326133416543549
   PubMed Web of Science ®Google Scholar
• PepinVSaeyDWhittomFLeBlancPMaltaisFWalking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20051721517152216166613
   PubMed Web of Science ®Google Scholar
• AguilaniuBPlaindouxABrossonCJeanmartMMaitreJDiabSDyspnea and handicap in chronic obstructive pulmonary disease: interaction of their mechanismsPresse Med20093841342019152776
   PubMed Web of Science ®Google Scholar
• FergusonGTRecommendations for the management of COPDChest200011723S28S10673470
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseasewww.goldcopd.com Accessed 12 Jan, 2009.
   Google Scholar
• LieskerJJWWijkstraPJTen HackenNHTKoeterGHPostmaDSKerstjensHAMA systematic review of the effects of bronchodilators on exercise capacity in patients with COPDChest200212159760811834677
   PubMed Web of Science ®Google Scholar
• SaeyDDebigareRLeBlancPMadorMJCoteCHJobinJContractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316842543012714348
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMIUWebbKASpirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916054254910430726
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMIUWebbKAMeasurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998158155715659817708
   PubMed Web of Science ®Google Scholar
• PittaFTakakiMYOliveiraNHSant’annaTJFontanaADKovelisDRelationship between pulmonary function and physical activity in daily life in patients with COPDRespir Med20081021203120718573647
   PubMed Web of Science ®Google Scholar
• O’DonnellDEVentilatory limitations in chronic obstructive pulmonary diseaseMed Sci Sports Exerc200133S647S65511462073
   PubMed Web of Science ®Google Scholar
• MarinJMCarrizoSJGasconMSanchezAGallegoBCelliBRInspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011631395139911371407
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFHamiltonAWebbKAguilaniuBEffects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in patients with COPDEur Respir J20042383284015218994
   PubMed Web of Science ®Google Scholar
• KillianKJLimitation to muscular activity in chronic obstructive pulmonary diseaseEur Respir J2004246715293597
   PubMed Web of Science ®Google Scholar
• HarverASchwartzsteinRMKillianKJMahlerDAO’DonnellDESerbyCWUnderstanding dyspnoea in COPD: mechanisms, measurement and managementEur Respir Rev2002122555
   Google Scholar
• RennardSDecramerMCalverleyPMAPrideNBSorianoJBVermierePAImpact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J20022079980512412667
   PubMed Web of Science ®Google Scholar
• Kline LeidyNFunctional performance in people with chronic obstructive pulmonary diseaseImage J Nurs Sch19952723347721307
   PubMedGoogle Scholar
• ATS/ACCP Statement on cardiopulmonary exercise testingAm J Respir Crit Care Med200316721127712524257
   PubMed Web of Science ®Google Scholar
• BeckKCWeismanIMMethods for cardiopulmonary exercise testingWeismanIMZeballosRJClinical Exercise TestingBaselKarger20024359
   Google Scholar
• MurrayJAWatermanLAWardJBairdJCMahlerDAPerceptual and physiologic responses during treadmill and cycle exercise in patients with COPDChest200913538439018753470
   PubMed Web of Science ®Google Scholar
• LacasseYWongEGuyattGHKingDCookDJGoldsteinRSMeta-analysis of respiratory rehabilitation in chronic obstructive pulmonary diseasesLancet1996348111511198888163
   PubMed Web of Science ®Google Scholar
• Puente-MaestuLVillarFde MiguelJStringerWWSanzPSanzMLClinical relevance of constant power exercise duration changes in COPDEur Respir J20093434034519251787
   PubMed Web of Science ®Google Scholar
• PuhanMAMadorMJHeldUGoldsteinRGuyattGHSchunemannHJInterpretation of treatment changes in 6-minute walk distance in patients with COPDEur Respir J20083263764318550610
   PubMed Web of Science ®Google Scholar
• ATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med200216611111712091180
   PubMed Web of Science ®Google Scholar
• RedelmeierDABayoumiAMGoldsteinRSGuyattGHInterpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patientsAm J Respir Crit Care Med1997155127812829105067
   PubMed Web of Science ®Google Scholar
• SinghSJMorganMDScottSWaltersDHardmanAEDevelopment of a shuttle walking test of disability in patients with chronic airways obstructionThorax199247101910241494764
   PubMed Web of Science ®Google Scholar
• SinghSJJonesPWEvansRMorganMDMinimum clinically important improvement for the incremental shuttle walking testThorax20086377577718390634
   PubMed Web of Science ®Google Scholar
• DreherMWalterspacherSSonntagFPrettinSKabitzHJWindischWExercise in severe COPD: is walking different from stair-climbingRespir Med200810291291818280129
   PubMed Web of Science ®Google Scholar
• SkumlienSHagelundTBjortuftORygMSA field test of functional status as performance of activities of daily living in COPD patientsRespir Med200610031632315941658
   PubMed Web of Science ®Google Scholar
• ZhanSCernyFJGibbonsWJMadorMJWuYWDevelopment of an unsupported arm exercise test in patients with chronic obstructive pulmonary diseaseJ Cardiopulm Rehabil20062618018716738459
   PubMedGoogle Scholar
• DechmanGSchererSOutcome measures in cardiopulmonary physical therapy: Focus on the Glittre ADL test for people with chronic obstructive pulmonary diseaseCardiopulmonary Physical Therapy Journal200819115118
   PubMedGoogle Scholar
• OzalevliSOzdenAItilOAkkocluAComparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary diseaseRespir Med200710128629316806873
   PubMed Web of Science ®Google Scholar
• HillCJDenehyLHollandAEMcDonaldCFMeasurement of functional activity in chronic obstructive pulmonary disease: the grocery shelving taskJ Cardiopulm Rehabil Prev20082840240919008696
   PubMed Web of Science ®Google Scholar
• LeitchAGHopkinJMEllisDAMerchantSMcHardyGJThe effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitisThorax197833711713154748
   PubMed Web of Science ®Google Scholar
• LeitchAGMorganAEllisDABellGHaslettCMcHardyGJEffect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitisThorax1981367877897036401
   PubMed Web of Science ®Google Scholar
• ShahSSJohnstonDWoodcockAAJohnsonMGeddesDMBreathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalationCurr Med Res Opin198383453496340975
   PubMed Web of Science ®Google Scholar
• CorrisPANevilleENarimanSGibsonGJDose-response study of inhaled salbutamol powder in chronic airflow obstructionThorax1983382922966867983
   PubMed Web of Science ®Google Scholar
• ConnollyCKChanNSSalbutamol and ipratropium in partially reversible airway obstructionBr J Dis Chest19878155612959307
   PubMedGoogle Scholar
• MohammedAFAndersonKMatusiewiczSPBoydGGreeningAPThomsonNCEffect of controlled-release salbutamol in predominantly non-reversible chronic airflow obstructionRespir Med1991854955001775676
   PubMed Web of Science ®Google Scholar
• BlosserSAMaxwellSLReeves-HocheMKRussell LocalioAZwillichCWIs an anticholinergic agent superior to a β2-agonist in improving dyspnea and exercise limitation in COPD?Chest19951087307357656624
   PubMed Web of Science ®Google Scholar
• OgaTNishimuraKTsukinoMSatoSHajiroTMishimaMA comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPDChest20031231810181612796154
   PubMed Web of Science ®Google Scholar
• AlivertiARodgerKDellacàRLStevensonNLoMAPedottiAEffect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPDThorax20056091692415994253
   PubMed Web of Science ®Google Scholar
• PortoEFCastroAAMNascimentoOOliveiraRCCardosoFJardimJRModulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise testsRespir Med200910325125718930646
   PubMed Web of Science ®Google Scholar
• WaltersEHWaltersJInhaled short acting beta2-agonist use in asthma: regular vs as needed treatmentCochrane Database Syst Rev2000CD00128511034709
   PubMedGoogle Scholar
• ShioyaTSatakeMSatoKSanoMASugawaraKTakahashiHLong-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily livingArzneimittelforschung200858242818368947
   PubMed Web of Science ®Google Scholar
• SukisakiTSenjyuHOishiKRikitomiNAriyoshiKSingle dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPDPhysiother Theory Pract20082425526318574751
   PubMedGoogle Scholar
• RennardSIAndersonWZuWallackRBroughtonJBaileyWFriedmanMUse of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011631087109211316640
   PubMed Web of Science ®Google Scholar
• LieskerJJVan De VeldeVMeysmanMVinckenWWollmerPHanssonLEffects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPDRespir Med20029655956612195835
   PubMed Web of Science ®Google Scholar
• WadboMLöfdahlCGLarssonKSkooghBETornlingGArweströmEEffects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled studyEur Respir J2002201138114612449166
   PubMed Web of Science ®Google Scholar
• AkkocaYOOnenZPDemirGErisGBSaryalSKarabiyikogluGIs there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patientsTuberk Toraks20065410511316924565
   PubMedGoogle Scholar
• PepinVBrodeurJLacasseYMilotJLeBlancPWhittomFSix-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary diseaseThorax20076229129817099077
   PubMed Web of Science ®Google Scholar
• O’DonnellDELavenezianaPOraJWebbKALamYMOfirDEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPDThorax20096421622319052054
   PubMed Web of Science ®Google Scholar
• OgaTNishimuraKTsukinoMHajiroTIkedaAIzumiTThe effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise testsAm J Respir Crit Care Med20001611897190110852763
   PubMed Web of Science ®Google Scholar
• WederMMDonohueJFRole of bronchodilators in chronic obstructive pulmonary diseaseSemin Respir Crit Care Med20052622123416088439
   PubMed Web of Science ®Google Scholar
• HayJGStonePCarterJChurchSEy-BrookAPearsonMGBronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary diseaseEur Respir J199256596641628722
   PubMed Web of Science ®Google Scholar
• TeramotoSFukuchiYOrimoHEffects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary diseaseChest1993103177417828404100
   PubMed Web of Science ®Google Scholar
• SpenceDPHayJGCarterJPearsonMGCalverleyPMOxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromideThorax199348114511508296259
   PubMed Web of Science ®Google Scholar
• IkedaANishimuraKKoyamaHSugiuraNIzumiTOxitropium bromide improves exercise performance in patients with COPDChest1994106174017457988193
   PubMed Web of Science ®Google Scholar
• TeramotoSFukuchiYImprovements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary diseaseAge Ageing1995242782827484482
   PubMed Web of Science ®Google Scholar
• TeramotoSMatsuseTSudoEOhgaEKatayamaHSuzukiMLong-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary diseaseIntern Med1996357727788933184
   PubMed Web of Science ®Google Scholar
• CukierAFerreiraCAStelmachRRibeiroMCortopassiFCalverleyPMThe effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPDRespir Med200710174675317000096
   PubMed Web of Science ®Google Scholar
• PetersMMWebbKAO’DonnellDECombined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPDThorax20066155956716467067
   PubMed Web of Science ®Google Scholar
• AalbersRAyresJBackerVDecramerMLierPAMagyarPFormoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trialEur Respir J20021993694312030736
   PubMed Web of Science ®Google Scholar
• NederJAFuldJPOverendTThirlwellJCarterRStevensonREffects of formoterol on exercise tolerance in severely disabled patients with COPDRespir Med20071012056206417658249
   PubMed Web of Science ®Google Scholar
• CazzolaMBiscioneGLPasquaFCrignaGAppodiaMCardaciVUse of 6-min and 12-min walking test for assessing the efficacy of formoterol in COPDRespir Med20081021425143018621519
   PubMed Web of Science ®Google Scholar
• WeinerPMagadleRBerar-YanayNDavidovichAWeinerMThe cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPDChest200011867267810988188
   PubMed Web of Science ®Google Scholar
• GuptaRKChhabraSKAn evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseasesIndian J Chest Dis Allied Sci20024416517212206475
   PubMedGoogle Scholar
• O’DonnellDEVoducNFitzpatrickMWebbKAEffect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary diseaseEur Respir J200424869415293609
   PubMed Web of Science ®Google Scholar
• ManWDCMustfaNNikoletouDKaulSHartNRaffertyGFEffect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPDThorax20045947147615170026
   PubMed Web of Science ®Google Scholar
• O’DonnellDESciurbaFCelliBMahlerDAWebbKAKalbergCJEffect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPDChest200613064765616963658
   PubMed Web of Science ®Google Scholar
• StockleyRAChopraNRiceLAddition of salmeterol to existing treatment in patients with COPD: a 12 month studyThorax20066112212816443706
   PubMed Web of Science ®Google Scholar
• BrouillardCPepinVMilotJLacasseYMaltaisFEndurance shuttle walking test: responsiveness to salmeterol in COPDEur Respir J20083157958418057052
   PubMed Web of Science ®Google Scholar
• MaltaisFHamiltonAMarciniukDHernandezPSciurbaFCRichterKImprovements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPDChest20051281168117816162703
   PubMed Web of Science ®Google Scholar
• CasaburiRKukafkaDCooperCBWitekTJJrKestenSImprovement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPDChest200512780981715764761
   PubMed Web of Science ®Google Scholar
• VerkindreCBartFAguilaniuBFortinFGuerinJCLe MerreCThe effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary diseaseRespiration20067342042716484769
   PubMed Web of Science ®Google Scholar
• OkudanNGokMGokbelHSuerdemMSingle dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary diseaseLung200618420120417006746
   PubMed Web of Science ®Google Scholar
• TraversJLavenezianaPWebbKAKestenSO’DonnellDEEffect of tiotropium bromide on the cardiovascular response to exercise in COPDRespir Med20071012017202417475459
   PubMed Web of Science ®Google Scholar
• AmbrosinoNFoglioKBalzanoGPaggiaroPLLessiPKestenSTiotropium and exercise training in COPD patients: effects on dyspnea and exercise toleranceInt J Chron Obstruct Pulmon Dis2008377178019281092
   PubMedGoogle Scholar
• CelliBZuWallackRWangSKestenSImprovement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumesChest20031241743174814605043
   PubMed Web of Science ®Google Scholar
• KestenSCasaburiRKukafkaDCooperCBImprovement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patientsInt J Chron Obstruct Pulmon Dis2008312713618488436
   PubMedGoogle Scholar